Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/18/10 → 6/30/13 |
Funding
- Janssen Alzheimer Immunotherapy Research and Development LLC: $16,772.00
Study of Bapineuzumab (AAB-001) Administered Subcutaneously At Monthly Intervals in Subjects with Mild to Moderate AD
- Jicha, Gregory (PI)
- Caban-Holt, Allison (CoI)